Clinical Trials Logo

Clinical Trial Summary

This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally abrupt and severe co-morbid neuropsychiatric symptoms, which include anxiety, emotional lability, depression, irritability, aggression, oppositionality, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. PANS is thought to be caused by infection, inflammation, or alternate triggers that is associated with a brain response that leads to these symptoms. The purpose of this study is to examine specific neurologic, immunologic, rheumatologic, and genomic, components in children with the acute-onset of psychiatric symptoms. This research may begin to uncover a much larger story of autoimmune processes that are involved in psychiatric disorders of childhood. By better understanding the etiologic components of psychiatric phenomenon, future treatments may be better targeted to underlying causes.


Clinical Trial Description

The investigators will recruit 500 children, 1-18 years old at onset with PANS/PANDAS. They will be treatment naive and within one month of onset/exacerbation. The 500 children with PANS will be gender- and age-matched to 100 healthy children, to allow examination of immunologic, neurologic, genomic, and behavioral differences between these two groups of children. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02889016
Study type Observational
Source Stanford University
Contact Joanne Cheung
Email pansresearch@stanford.edu
Status Recruiting
Phase N/A
Start date March 2013
Completion date March 2028

See also
  Status Clinical Trial Phase
Recruiting NCT04015596 - Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS Phase 4
Completed NCT01617083 - Antibiotic Treatment Trial for the PANDAS/PANS Phenotype Phase 2
Completed NCT04382716 - Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Characterization and Prospective Course
Completed NCT02190292 - PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort
Withdrawn NCT01769027 - Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS Phase 2
Completed NCT01281969 - Intravenous Immunoglobulin for PANDAS Phase 3